Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2020 · 10-Q
Revenue$194.68M$194.68M+5.3% vs Q3 2019 Net Income$36.43M$36.43M−18.4% vs Q3 2019 EPS Diluted$0.92$0.92−20.0% vs Q3 2019 Gross Profit$130,063,000+4.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$49,469,000+24.7% Free Cash Flowderived$40,187,000+15.7% Margins · derivedGross margin66.8%−0.6 pt vs Q3 2019
Operating margin24.5%+0.7 pt vs Q3 2019
Net margin18.7%−5.4 pt vs Q3 2019
ended Mar 31, 2020 · filed May 11, 2020 · 41 d after period end